Skip to main content
An official website of the United States government

Companies Formed by PIs of the NCI Alliance for Nanotechnology in Cancer

Over the years, many investigators in the Alliance have transferred their technologies in the form of patents and start-up companies.  The Alliance model for translational research is that discoveries made in academic laboratories are handed off to for-profit partners for efficient development into research and clinical products. Alliance members have been eager to bring their technology to the clinic, forming over 100 start-up companies and partnerships with existing biotechnology firms. Many of these start-ups are thriving and now offer products, research or consulting services to the academic and clinical communities. Others have attracted significant investment from large pharmaceutical companies and venture capital funds.

  • Posted: